DeutschNewstral
Article
bizjournals.com on 2015-01-06 20:15
Developer of synthetic cannabinoid therapies expands management team
Related news
- Main Line synthetic cannabinoid developer seeking $32.5M from stock salebizjournals.com
- Synthetic cannabinoid therapy developer goes public in $42M IPObizjournals.com
- Main Line pharma company developing synthetic cannabinoid therapies narrows its focusbizjournals.com
- TSynthetic cannabinoid reduces sleep apneatoday.uic.edu
- Cortendo expands its management teambizjournals.com
- GFourth synthetic cannabinoid related death reportedgreeneprairiepress.com
Local health officials issue synthetic cannabinoid warningpikepress.com- Chester Co. firm's synthetic cannabinoid gel starts next testing phasebizjournals.com
Bleeding from synthetic cannabinoid use causing illness, deathal.com
Federal charges for Adams man in "massive" synthetic cannabinoid operationberkshireeagle.com
Synthetic Cannabinoid Spice Products Linked To Unusual Severe Bleeding CasesForbes
Synthetic Cannabinoid Key Ingredient In Bad K2 Batchnewhavenindependent.org- GSynthetic Cannabinoid Market – Global Outlook and Forecast 2022-2028galleonnews.com
Health department warns over synthetic cannabinoid death threatrockrivertimes.com- TBoard of Aldermen begins exploration of synthetic cannabinoid banthesomervilletimes.com
Synthetic Cannabinoid Users Can Exhibit Bizarre and Violent Behaviorsbirminghamtimes.com- Federal charges for Adams man in 'massive' synthetic cannabinoid operationberkshireeagle.com
12 teens hospitalized after taking illegal synthetic cannabinoid drugtimesofisrael.com- National wealth management firm expands into Philadelphia regionbizjournals.com